Clinicopathological characteristics of the study cohort
| Clinicopathological characteristics | SCC | AC | P - value |
|---|---|---|---|
| Number of patients | 103 | 33 | – |
| Age | 0.103(#) | ||
| Mean | 44.25 | 41.39 | |
| Min | 24 | 23 | |
| Max | 81 | 72 | |
| FIGO stage | 0.856 | ||
| IBI | 60 (58.2) | 20 (60.6) | |
| > = IBII | 42 (40.8) | 13 (39.4) | |
| Missing | 1 (1) | 0 (0.0) | |
| Tumor size | 0.448 | ||
| < =4 cm | 72 (69.9) | 25 (75.8) | |
| > 4 cm | 29 (28.2) | 7 (21.2) | |
| Missing | 2 (1.9) | 1 (3.0) | |
| Vaginal involvement | 0.191* | ||
| Yes | 17 (16.5) | 1 (3.0) | |
| No | 84 (81.6) | 22 (66.7) | |
| Missing | 2 (1.9) | 10 (30.3) | |
| Parametrium invasion | 0.122 | ||
| Yes | 38 (36.9) | 7 (21.2) | |
| No | 63 (61.2) | 24 (72.7) | |
| Missing | 2 (1.9) | 2 (6.1) | |
| Progression | 0.303 | ||
| Yes | 32 (31.1) | 13 (39.4) | |
| No | 65 (63.1) | 14 (42.4) | |
| Missing | 6 (5.8) | 6 (18.2) | |
| Recurrence in 5 years | 0.014 | ||
| Yes | 30 (29.1) | 18 (54.5) | |
| No | 64 (62.1) | 14 (42.4) | |
| Missing | 9 (8.7) | 1 (3.0) | |
Progression: determined by physical examination, pathological or radiological assessment
Recurrence: recurrence after a complete remission due to the treatment
P-value measured with Asymptotic Pearson Chi2; (*)Exact test was used when counts were less than 5; (#)Mann-Whitney U Test was used for mean comparison
Data shown as n (%)
FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, AC adenocarcinoma